Skip to content

Analysis of coagulation and fibrinolytic markers in DIC patients complicated by various underlying diseases

Analysis of coagulation and fibrinolytic markers in DIC patients complicated by various underlying diseases - Analysis of coagulation and fibrinolytic markers in DIC patients complicated by various underlying diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032972
Enrollment
5000
Registered
2018-06-15
Start date
2017-08-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DIC

Interventions

None listed

Sponsors

Fukusima Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who are admitted to the hospital to treat the anderlying disease and supposed to develop DIC should be recruited. PLT less than or equal to 12x103/uL, fibrinogen less than or equal to 150mg/dL, FDP grater than or equal to 10ug/mL, 16 years of age or older.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Survival rate of DIC patients at day 28 Dynamics of coagulation markers Rate of DIC withdrawal and duration between diagnosis and withdrawal from DIC Type of DIC treatment and its duration Type and severity of underlying disease Overall survival

Countries

Japan

Contacts

Public ContactTakayuki Ikezoe

Fukushima Medical University Department of Hematology

ikezoet@fmu.ac.jp024-547-1193

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026